Sample menu:

Macedonian Veterinary Review


p-ISSN 1409-7621
e-ISSN 1857-7415

Co-publishing with:
De Gruyter

Abstract / References

Origibal Scientific Article

Vascular endothelial growth factor (VEGF) in abdominal fluid in dogs with oncological and non-oncological diseases
Tsanko Hristov
Department of Internal Non-Infectious Diseases, Faculty of Veterinary Medicine, Trakia University, Stara Zagora 6000, Bulgaria


The vascular endothelial growth factor (VEGF) is a multifunctional cytokine stimulating the growth of vascular endothelial cells, survival and proliferation, inhibiting apoptosis. It is one of the most potent stimulants of vascular permeability. VEGF is found at high levels in inflammatory and tumour-associated pleural and abdominal effusions and is involved in their occurrence. In the present study, the blood plasma and abdominal fluid VEGF levels were assayed in thirty-one client-owned dogs with neoplastic and non-neoplastic diseases by means of enzyme-linked immunosorbent assay (ELISA). The VEGF concentration in abdominal fluid of dogs (n=6) with ascites was 190.70±34.35 pg/ml, in dogs (n=6) with peritonitis: 1449.81±365.42 pg/ml and in dogs (n=9) with tumour-associated effusion: 1993.13±202.56 pg/ml. Blood plasma VEGF of healthy dogs (control group, n=10) was 36.79±5.72 pg/ml, in dogs with ascites: 57.92±2.88 pg/ml, in dogs with peritonitis: 76.98±7.24 pg/ml and in dogs with tumour-associated effusion: 173.50±40.9 pg/ml. There were substantial differences between blood plasma and abdominal fluid VEGF levels.
Key words: vascular endothelial growth factor, abdominal fluid, tumours, dogs

Mac Vet Rev 2019; 42 (2): i-vi
[ PDF Free Article ] pdf Linija          
Available Online First:31 August 2019

    1. Ferrara, N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 25(4): 581-611.

    2. Pidgeon, GP., Barr, MP., Harmey, JH., Foley, DA., Bouchier-Hayes, DJ. (2001). Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer. 85(2): 273-278.
    PMid:11461089 PMCid:PMC2364032

    3. Takano, Т., Ohyama, T., Kokumoto, A., Satoh, R., Hohdatsu, Ts. (2011). Vascular endothelial growth factor (VEGF), produced by feline infectious peritonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP. Virus Research 158, 161-168.

    4. Zhao, X., Xian, S., Xiao-li, L. (2012) Expression and clinical significance of STAT3, P-STAT3, and VEGF-C in small cell lung cancer. Asian Pacific J Cancer Prev. 13, 2873-2877.

    5. Ghasemi, M., Omid, E., Farshad, N., Ahmadreza, B., Saeid, A., Laleh, V., Moghimpour, R. (2011). Immunohistochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma. Acta Medica Iranica 49(12): 776-779.

    6. Stefanou, D., Anna, B., Sevasti, K., Evdokia, A., Dionysios, J.P., Niki, J.A. (2004). Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo 18 (2): 155-160.

    7. Campos, A.G., Campos, J. A., Sanches, D. S., Dagli, M. L., Matera, J. M. (2012). Immunohistochemical evaluation of vascular endothelial growth factor (VEGF) in splenic hemangiomas and hemangiosarcomas in dogs. Open Journal of Veterinary Medicine 2, 191-195.

    8. Martano, M., Restucci, B., Ceccarelli, D. M., Muzio, L. L., Maiolino, P. (2016). Immunohistochemical expression of vascular endothelial growth factor in canine oral squamous cell carcinomas. Oncology Letters 11, 399-404.
    PMid:26870224 PMCid:PMC4727185

    9. Millanta, F., Andreani, G., Rocchigiani, G., Lorenzi, D., Poli, A. (2016). Correlation between cyclo-oxygenase-2 and vascular endothelial growth factor expression in canine and feline squamous cell carcinomas. J Comp Pathol. 154(4): 297-303.

    10. Barrientos, S., Olivera, S., Michael, S.G., Harold, B., Marjana, T. (2008). Growth factors and cytokines in wound healing. Wound Rep Reg. 16, 585-601.

    11. Robinson, R.S., Woad, K.J., Hammond, A.J., Laird ,M., Hunter, M.G., Mann, G.E. (2009). Angiogenesis and vascular function in the ovary. Reproduction 138, 869-881.

    12. Sack, U., Hoffmann, M., Zhao, X.J., Chan, K.S., Hui, D.S.C., Gosse, H., Engelmann, L., Schauer, J., Emmrich, F., Hoheisel, G. (2005). Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J. 25, 600-604.

    13. Bekes, I., Thomas, W.P.F., Tanja, K., Volker, M., Wolfgang, J., Achim, W., Wulff, C. (2016). Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer? Molecular Cancer 15, 13.
    PMid:26868378 PMCid:PMC4751711

    14. Sun, X., Dong, W., Gao, L., Jiang, X. (2003). Detection of VEGF levels in ascites and peritoneal fluid. Chinese Journal of Cancer Research 15(4): 310-314.

    15. Askari, V.R., Vafa, B.R., Parvin, Z., Narges, F., Pouria, R., Amir, H.S., Rakhshandeh, H. (2018). Evaluation of the effects of Iranian propolis on the severity of post operational-induced peritoneal adhesion in rats. Biomedicine & Pharmacotherapy 99, 346-353.

    16. Clifford, C.A., Dez, H., Matthew, W.B., Carolyn, J.H., Kenneth, J.D., Karin, U.S. (2002). Vascular endothelial growth factor concentrations in body cavity effusions in dogs. J Vet Intern Med. 16,164-168.

    17. Wergin, M.C., Kaser-Hotz, B. (2004). Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. In Vivo 18(1): 15-19.

    18. Kato, Y., Asano, K., Mogi, T., Kutara, K., Teshima, K., Edamura, K. Tsumagari, S., Hasegawa, A., Tanaka, S. (2007). Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors. J Vet Med Sci. 69(1): 77-80.

    19. Wolfesberger, B., de Arespacohaga, G., Willmann, A., Gerner, M., Miller, W., Schwendenwein, I., et al. (2007). Expression of vascular endothelial growth factor and its receptors in canine lymphoma. Journal of Comparative Pathology 137(1): 30-40.

    20. Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marme, D., Gastl, G. (1999). Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (Phila). 85, 178-187.<178::AID-CNCR25>3.0.CO;2-7

    21. Rudlowski, C., Pickart, A.K., Fuhljahn, C., Friepoertner, T., Schlehe, B., Biesterfeld, S., Schroeder, W. (2006). Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Int J Gynecol Cancer. 16(1): 183-189.

    22. Roskoski, J.R. (2007). Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical Reviews in Oncology/Hematology 62, 179-213.

    23. Dvorak, H.F. (2002). Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. Journal of Clinical Oncology 20(21): 4368-4380.

    24. Queiroga, F.L., Pires, I., Parente, M., Gregório, H., Lopes, C.S. (2011). COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer. Vet J. 189(1): 77-82.






cope This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.
Creative Commons License
The all content of the Journal "Mac Vet Rev", except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.